Capital Fund Management (CFM)’s Roivant Sciences ROIV Stock Holding History

Capital Fund Management (CFM)’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$482K	Sell	17,400 -14,200	-45%	-$365K	﹤0.01%	1885
2025 Q4	$686K	Buy	31,600 +2,300	+8%	+$45.4K	﹤0.01%	2138
2025 Q3	$443K	Buy	+29,300	New	+$363K	﹤0.01%	2326

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Fund Management (CFM)'s ROIV Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Roivant Sciences (ROIV) in Q1 2026: 17,297 shares worth $479K. The stake represents ﹤0.01% of the portfolio and ranks #1886 among its holdings.

439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Capital Fund Management (CFM) held 17,297 shares of Roivant Sciences worth $479K as of Q1 2026.
Roivant Sciences was a new Capital Fund Management (CFM) position in Q1 2026.
Roivant Sciences made up ﹤0.01% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #1886 holding.
439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.